ScreenerHero

PULMPulmatrix, Inc.

NAS · US · Healthcare · Biotechnology · pulmatrix.com
1.495USD-1.64%Mkt Cap: 5.46M $P/E: —

Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap5.46M $
Enterprise Value4.28M $
Revenue (TTM)—
Gross Profit-38.00K $
Net Income (TTM)-5.16M $
Revenue/Share—
Last Price1.495 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS74584P3010
Valuation
P/E (Trailing)—
P/E (Forward)-0.33
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B3.44
EPS (TTM)-1.09
EPS (Forward)-4.50
52W Range
1.1608% of range5.498
52W High5.498 USD
52W Low1.160 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-135.49%
ROA-124.72%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.43M $
CapEx (TTM)—
FCF Margin—
FCF Yield-57.84%
Net Debt-2.17M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio4.70
Quick Ratio3.15
Book Value/Sh0.4360 USD
Cash/Share0.5940 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateFeb 6, 2019
Splits
Last Split1:20
Split DateMar 1, 2022
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.65M
Float3.65M
Insiders0.77%
Institutions9.16%
Short Interest
Short Ratio0.8d
Short % Float0.46%
Short % Out.0.46%
Shares Short16.79K
Short (prev mo.)91.27K
Technical
SMA 501.621 (-7.8%)
SMA 2002.274 (-34.3%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)16.08K
Avg Vol (10d)10.39K
Technical Indicators
RSI (14)39.0
MACD-0.0289
MACD Signal-0.0051
MACD Hist.-0.0238
BB Upper1.805 USD
BB Middle1.640 USD
BB Lower1.474 USD
BB Width20.20%
ATR (14)0.0812 USD
Vol Ratio (20d)3.80x